Lifescience Global

Journal of Analytical Oncology

AnalyticalOncologywebAbout the Journal 

Co-Editor-in-Chief : Amedeo Amedei View Profile
        
Abbreviated key title: J. Anal. Oncol.
ISSN (online): 1927-7229
Published by: Lifescience Global
Periodicity: 4 times per year
Months: January, April, July, October
contact us for more information
Abstracted & Indexed in:  Chemical Abstracts, Open J-Gate, SCOPUS

image002

Scope and Topics of the Journal

Analytical Oncology is a peer reviewed journal which encompasses wholly analytical aspects of the malignant disease. This comprises detections, therapy, preclinical methods, prevention, diagnosis, follow-up, and optimization and individualization of therapies.

The fundamental purpose is to deliver a unique interdisciplinary forum. Investigations connected to the etiology, diagnosis, and the treatments of cancers, as well as research from related disciplines of interest is published.

Research themes included but not limited to biomarker, pharmacogenomics, biochemistry, pharmacokinetics, drug monitoring, dose individualization, drug targeting, drug metabolism, laboratory diagnostics, other diagnostic procedures, tumour and microbiology.

Indexed and Abstracted in

Chemical Abstracts, OCLC (WorldCat), World Health Organization – HINARI, Open J-Gate, Google Scholar, SCOPUS, EZB Nutzeranfragen, PubsHub™

Audience

The journal is addressed to both practicing professionals and researchers in the field of oncology, professionals in academia, former researchers and PhD students and other specialists interested in the results of scientific cancer research.

Peer Review Policy

All journals published by Lifescience Global follow the peer review system designed for each article published.

  • Manuscript topics are normally approved by senior editors followed by formal peer review conducted in collaboration with editorial board members and independent referees appointed by editorial team of each journal.
  • In case of theme issue on a particular topic, the appointed Guest Editor is responsible to conduct peer review and submit full review reports along with accepted manuscripts of the journal.
  • Lifescience Global encourages its editorial teams to use the electronic submission and peer-review system for its journals to facilitate them during peer review process.

Publication Ethics and Publication Malpractice Statement

Publication Ethics and Publication Malpractice Statement

Fee Waiver

Lifescience Global allows FEE Waiver to authors from any of the below countries which were classified by the World Bank as Low-income economies or Lower-middle-income economies as of September 2012 (reference - World Bank 1st September 2012).

List of Countries:

Afghanistan
Benin
Burundi
Central African Republic
Congo, Rep.
Eritrea
Georgia
Guinea-Bissau
Iraq
Kosovo
Liberia
Marshall Islands
Mongolia
Nepal
Paraguay
Sierra Leone
Sudan
Tajikistan
Tonga
Yemen, Rep.
Albania
Bhutan
Cambodia
Chad
Côte d'Ivoire
Ethiopia
Ghana
Guyana
Kenya
Kyrgyz Republic
Madagascar
Mauritania
Morocco
Nicaragua
Rwanda
Solomon Islands
Swaziland
Tanzania
Uganda
Zambia

Armenia
Bolivia
Cameroon
Comoros
Djibouti
Fiji
Guatemala
Haiti
Kiribati
Lao PDR
Malawi
Micronesia, Fed. Sts.
Mozambique
Niger
Samoa
Somalia
Syrian Arab Republic
Timor-Leste
Vanuatu
Zimbabwe
Belize
Burkina Faso
Cape Verde
Congo, Dem. Rep
El Salvador
Gambia, The
Guinea
Honduras
Korea, Dem Rep.
Lesotho
Mali
Moldova
Myanmar
Papua New Guinea
Senegal
South Sudan
São Tomé and Principe
Togo
West Bank and Gaza

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn

OUR STRENGTHS

♦  Worldwide readership
♦  High quality content
♦  Maximum visibility
♦  Efficient publishing
♦  Optional Open Access

Publish your Research

Survey

As an author what type of publishing model you prefer?

780
Open Access
493
Optional Open Access
338
Subscription based
5 Votes left